CY1107187T1 - Φαρμακευτικη σωματιδιακη συνθεση παρατεταμενης απελευθερωσης η οποια περιεχει βενλαφαξινη - Google Patents
Φαρμακευτικη σωματιδιακη συνθεση παρατεταμενης απελευθερωσης η οποια περιεχει βενλαφαξινηInfo
- Publication number
- CY1107187T1 CY1107187T1 CY20081100161T CY081100161T CY1107187T1 CY 1107187 T1 CY1107187 T1 CY 1107187T1 CY 20081100161 T CY20081100161 T CY 20081100161T CY 081100161 T CY081100161 T CY 081100161T CY 1107187 T1 CY1107187 T1 CY 1107187T1
- Authority
- CY
- Cyprus
- Prior art keywords
- venlafaxine
- pharmaceutical
- venlafachin
- long
- particular composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Μέθοδος παρασκευής μιας φαρμακευτικής σύνθεσης η οποία περιέχει βενλαφαξίνη ή φαρμακευτικώς αποδεκτό άλας της η οποία περιλαμβάνει τις βαθμίδες (1) παρασκευής ενός εναιωρήματος βενλαφαξίνης ή άλατος βενλαφαξίνης εντός διαλύτη στον οποίο η βενλαφαξίνη ή τα άλατα βενλαφαξίνης έχουν διαλυτότητα μικρότερη από 25g/l σε θερμοκρασία δωματίου, (2) μετατροπής του εναιωρήματος της βαθμίδας (1) σε σωματιδιακή μορφή, (3) επίστρωσης των σωματιδίων που ελήφθησαν στη βαθμίδα (2) με μια στιβάδα πολυμερούς παρατεταμένης απελευθέρωσης, καθώς και φαρμακευτικές συνθέσεις που λαμβάνονται με αυτή τη μέθοδο.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004036641A DE102004036641A1 (de) | 2004-07-28 | 2004-07-28 | Verzögert freisetzende pharmazeutische Zusammensetzung, die Venlafaxin enthält |
EP05768606A EP1778193B1 (en) | 2004-07-28 | 2005-07-27 | Sustained release pharmaceutical particulate composition comprising venlafaxine |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1107187T1 true CY1107187T1 (el) | 2012-10-24 |
Family
ID=35106687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20081100161T CY1107187T1 (el) | 2004-07-28 | 2008-02-13 | Φαρμακευτικη σωματιδιακη συνθεση παρατεταμενης απελευθερωσης η οποια περιεχει βενλαφαξινη |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1778193B1 (el) |
AT (1) | ATE381925T1 (el) |
CY (1) | CY1107187T1 (el) |
DE (2) | DE102004036641A1 (el) |
DK (1) | DK1778193T3 (el) |
EA (1) | EA009957B1 (el) |
ES (1) | ES2299061T3 (el) |
HR (1) | HRP20080007T3 (el) |
NO (1) | NO20071139L (el) |
PL (1) | PL1778193T3 (el) |
PT (1) | PT1778193E (el) |
RS (1) | RS50572B (el) |
SI (1) | SI1778193T1 (el) |
UA (1) | UA83437C2 (el) |
WO (1) | WO2006010605A2 (el) |
ZA (1) | ZA200701554B (el) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10722458B2 (en) * | 2011-12-02 | 2020-07-28 | Pegasus Laboratories, Inc. | Amphipathic lipid-based sustained release compositions |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL146462A (en) * | 2001-11-13 | 2015-02-26 | Lycored Bio Ltd | Prolonged-release preparations containing as an active compound and analapaxin hydrochloride |
EP1474123A1 (en) * | 2002-01-03 | 2004-11-10 | LEK Pharmaceuticals D.D. | Controlled release pharmaceutical formulation containing venlafaxine |
CN1674877A (zh) * | 2002-06-07 | 2005-09-28 | 兰贝克赛实验室有限公司 | 控释的多单位药物释放系统 |
PL377473A1 (pl) * | 2002-11-28 | 2006-02-06 | Themis Laboratories Private Limited | Sposób produkcji mikropeletek o przedłużonym uwalnianiu zawierających chlorowodorek wenlafaksyny |
-
2004
- 2004-07-28 DE DE102004036641A patent/DE102004036641A1/de not_active Withdrawn
-
2005
- 2005-07-27 EP EP05768606A patent/EP1778193B1/en active Active
- 2005-07-27 DK DK05768606T patent/DK1778193T3/da active
- 2005-07-27 EA EA200700159A patent/EA009957B1/ru not_active IP Right Cessation
- 2005-07-27 SI SI200530187T patent/SI1778193T1/sl unknown
- 2005-07-27 ES ES05768606T patent/ES2299061T3/es active Active
- 2005-07-27 RS RSP-2008/0116A patent/RS50572B/sr unknown
- 2005-07-27 UA UAA200700846A patent/UA83437C2/uk unknown
- 2005-07-27 AT AT05768606T patent/ATE381925T1/de active
- 2005-07-27 DE DE602005004033T patent/DE602005004033T2/de active Active
- 2005-07-27 PT PT05768606T patent/PT1778193E/pt unknown
- 2005-07-27 PL PL05768606T patent/PL1778193T3/pl unknown
- 2005-07-27 WO PCT/EP2005/008149 patent/WO2006010605A2/en active Application Filing
-
2007
- 2007-02-22 ZA ZA200701554A patent/ZA200701554B/en unknown
- 2007-02-28 NO NO20071139A patent/NO20071139L/no not_active Application Discontinuation
-
2008
- 2008-01-09 HR HR20080007T patent/HRP20080007T3/xx unknown
- 2008-02-13 CY CY20081100161T patent/CY1107187T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
ATE381925T1 (de) | 2008-01-15 |
EA009957B1 (ru) | 2008-04-28 |
WO2006010605A2 (en) | 2006-02-02 |
DK1778193T3 (da) | 2008-02-04 |
DE602005004033T2 (de) | 2009-01-02 |
RS50572B (sr) | 2010-05-07 |
ZA200701554B (en) | 2008-05-28 |
DE102004036641A1 (de) | 2006-03-23 |
WO2006010605A3 (en) | 2006-09-21 |
EP1778193B1 (en) | 2007-12-26 |
ES2299061T3 (es) | 2008-05-16 |
DE602005004033D1 (de) | 2008-02-07 |
NO20071139L (no) | 2007-02-28 |
UA83437C2 (uk) | 2008-07-10 |
PL1778193T3 (pl) | 2008-05-30 |
PT1778193E (pt) | 2008-03-10 |
SI1778193T1 (sl) | 2008-06-30 |
EA200700159A1 (ru) | 2007-06-29 |
HRP20080007T3 (en) | 2008-01-31 |
EP1778193A2 (en) | 2007-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008007151A3 (en) | Processes for preparing pharmaceutical compositions | |
WO2009154777A3 (en) | Process for preparing and drying solid rasagiline base | |
ATE536864T1 (de) | Metoprololsuccinat tabletten mit verlängerter freisetzung und verfahren für deren herstellung | |
NO20070871L (no) | Multipartikkelformulering | |
NO20064934L (no) | Fremgangsmate for fremstilling av et fast, farmasoytisk preparat | |
NO20071944L (no) | Hydrolysestabil beleggingsmiddelsammensetning | |
WO2008125120A3 (en) | Extract of trigonella foenum-graecum | |
WO2007147771A3 (en) | Tetralin and indane derivatives and uses thereof | |
BRPI0506283A (pt) | composição, método, e, artigo | |
UA99447C2 (ru) | Способ получения силденафила | |
NZ592882A (en) | Mucoadhesive film comprising testosterone and cellulose derivatives | |
MX2008001560A (es) | Nuevos compuestos analogos de la camptotecina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
WO2010007312A3 (fr) | Procede de fabrication de films directement en alveole | |
WO2009007992A8 (en) | Pharmaceutical composition produced by microprecipitation | |
WO2009020430A3 (en) | Method of forming a cadmium containing nanocrystal | |
WO2009152211A3 (en) | Initiator system with biphenylene derivates, method of production and use thereof | |
WO2008073863A3 (en) | Preparation and utility of substituted allylamines | |
WO2010020799A3 (en) | Compositions for the treatment of neoplastic diseases | |
DK1871180T3 (da) | Fremgangsmåde til tørring af uronsyreoligosaccharider | |
EP2551266A8 (en) | 2',2-dithiazol non-nucleoside compounds, preparation methods, pharmaceutical compositions and uses as hepatitis virus inhibitors thereof | |
CY1107187T1 (el) | Φαρμακευτικη σωματιδιακη συνθεση παρατεταμενης απελευθερωσης η οποια περιεχει βενλαφαξινη | |
WO2008084823A1 (ja) | 褐色皮膜組成物およびその調製方法 | |
WO2009013760A3 (en) | Eprosartan mesylate crystalline particles and a process for preparing pure eprosartan | |
TW200702926A (en) | Compound dissolution inhibiting agent, positive resist composition, and resist pattern formation method | |
WO2008017020A3 (en) | Process for preparing proton pump inhibitors |